foxo4-dri senolytic 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound foxo4 dri peptide senolytic 2024

Recovery depends on injury severity

We do not allow the human consumption of our products

Use of unregulated research-chemical peptides carries quality-control and contamination risk, and there is no long-term human safety data for either compound

Protocol at a Glance: Dose: 250-500mcg daily Frequency: Once daily (can split to 2x if needed) Method: SubQ injection near injury or abdomen Duration: 4-8 weeks minimum Cost: $40-60 for 4-week cycle Results Timeline: Week 1-2: 30-50% pain reduction Week 3-4: 60-80% improvement in mobility Week 6-8: 80-95% healed (most users) Most users notice pain reduction within 1-2 weeks, with near-complete healing by week 6-8